Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-6292
Authors: Barco, Stefano
Sollfrank, Stefanie
Trinchero, Alice
Adenaeuer, Anke
AbolghasemI, Hassan
Conti, Laura
Häuser, Friederike
Kremer Hovinga, Johanna A.
Lackner, Karl J.
Loewecke, Felicia
Miloni, Erwin
Vazifeh Shiran, Nader
Tomao, Luigi
Wuillemin, Walter A.
Zieger, Barbara
Lämmle, Bernhard
Rossmann, Heidi
Title: Severe plasma prekallikrein deficiency : clinical characteristics, novel KLKB1 mutations, and estimated prevalence
Online publication date: 17-Aug-2021
Language: english
Abstract: BACKGROUND Severe plasma prekallikrein (PK) deficiency is an autosomal-recessive defect characterized by isolated activated partial thromboplastin time prolongation. To date, no comprehensive methodologically firm analysis has investigated the diagnostic, clinical, and genetic characteristics of PK deficiency, and its prevalence remains unknown. PATIENTS/METHODS We described new families with PK deficiency, retrieved clinical and laboratory information of cases systematically searched in the (gray) literature, and collected blood of these cases for complementary analyses. The Genome Aggregation Database (gnomAD) and the population-based Gutenberg Health Study served to study the prevalence of mutations and relevant genetic variants. RESULTS We assembled a cohort of 111 cases from 89 families and performed new genetic analyses in eight families (three unpublished). We identified new KLKB1 mutations, excluded the pathogenicity of some of the previously described ones, and estimated a prevalence of severe PK deficiency of 1/155 668 overall and 1/4725 among Africans. One individual reported with PK deficiency had, in fact, congenital kininogen deficiency associated with decreased PK activity. One quarter of individuals had factor XII clotting activity below the reference range. Four major bleeding events were described in 96 individuals, of which 3 were provoked, for a prevalence of 4% and an annualized rate of 0.1%. The prevalence of cardiovascular events was 15% (6% <40 years; 21% 40-65 years; 33% >65 years) for an annualized rate of 0.4%. CONCLUSIONS We characterized the genetic background of severe PK deficiency, critically appraised mutations, and provided prevalence estimates. Our data on laboratory characteristics and clinical course of severe PK deficiency may have clinical implications.
DDC: 610 Medizin
610 Medical sciences
Institution: Johannes Gutenberg-Universität Mainz
Department: FB 04 Medizin
Place: Mainz
DOI: http://doi.org/10.25358/openscience-6292
Version: Published version
Publication type: Zeitschriftenaufsatz
License: CC BY-NC
Information on rights of use: https://creativecommons.org/licenses/by-nc/4.0/
Journal: Journal of thrombosis and haemostasis
18
7
Pages or article number: 1598
1617
Publisher: Wiley-Blackwell
Publisher place: Oxford
Issue date: 2020
ISSN: 1538-7836
Publisher URL: https://doi.org/10.1111/jth.14805
Publisher DOI: 10.1111/jth.14805
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
barco_stefano-severe_plasma_-20210817090751895.pdf1.16 MBAdobe PDFView/Open